This company listing is no longer active
IVACC BTA Stock Overview
Develops novel veterinary vaccines for animals in Sweden. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Intervacc AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 7.90 |
52 Week High | SEK 9.00 |
52 Week Low | SEK 4.53 |
Beta | 0.97 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 56.75% |
Recent News & Updates
Recent updates
Shareholder Returns
IVACC BTA | SE Biotechs | SE Market | |
---|---|---|---|
7D | 56.7% | 0.04% | 2.8% |
1Y | n/a | 11.8% | 14.9% |
Return vs Industry: Insufficient data to determine how IVACC BTA performed against the Swedish Biotechs industry.
Return vs Market: Insufficient data to determine how IVACC BTA performed against the Swedish Market.
Price Volatility
IVACC BTA volatility | |
---|---|
IVACC BTA Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 8.5% |
Market Average Movement | 5.7% |
10% most volatile stocks in SE Market | 12.0% |
10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: IVACC BTA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IVACC BTA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 15 | Andreas Andersson | www.intervacc.se |
Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company develops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles.
Intervacc AB (publ) Fundamentals Summary
IVACC BTA fundamental statistics | |
---|---|
Market cap | SEK 636.18m |
Earnings (TTM) | -SEK 70.91m |
Revenue (TTM) | SEK 11.71m |
54.3x
P/S Ratio-9.0x
P/E RatioIs IVACC BTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IVACC BTA income statement (TTM) | |
---|---|
Revenue | SEK 11.71m |
Cost of Revenue | SEK 9.15m |
Gross Profit | SEK 2.56m |
Other Expenses | SEK 73.47m |
Earnings | -SEK 70.91m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 31, 2023
Earnings per share (EPS) | -0.94 |
Gross Margin | 21.86% |
Net Profit Margin | -605.53% |
Debt/Equity Ratio | 0.07% |
How did IVACC BTA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/06/14 02:05 |
End of Day Share Price | 2023/06/13 00:00 |
Earnings | 2023/03/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Intervacc AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jakob Lembke | ABG Sundal Collier Sponsored |
Lars Hevreng | Danske Bank |
Henrik Holmer | Penser Access |